Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic Properties of the GPR40 Agonist TAK‐875: Results From a Double‐Blind, Placebo‐Controlled Single Oral Dose Rising Study in Healthy Volunteers
PaperCitations, authors & open-access status
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic Properties of the GPR40 Agonist TAK‐875: Results From a Double‐Blind, Placebo‐Controlled Single Oral Dose Rising Study in Healthy Volunteers is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 88 citations, 2011 year and closed oa status.
88
Citations
2011
Year
closed
OA Status